---
title: "Creating a New Way Forward"
cta: Learn more
link: values
image: /img/hero-journey.svg
blurb:
    text: "Working closely with leading cancer centers, community oncology clinics, and teams of patients, Blue Note is developing clinically validated prescription digital therapeutics to help reduce anxiety, depression, and other distress related to cancer."
people:
    heading: Leadership
    description: 
    items:
        - name: Geoff Eich
          title: CEO
          image: /img/profile-geoff.png
        - name: Rick Lit
          title: Scientific Operations
          image: /img/profile-rick.png
        - name: Michael McKinley
          title: Product Development
          image: /img/profile-mikemc.png
        - name: Michael Malecki
          title: Access & Reimbursement
          image: /img/profile-malecki.png
        - name: Mark Elfers
          title: Finance & Operations
          image: /img/profile-mark.png
        - name: Laura Chavaree
          title: Patient Engagement
          image: /img/profile-laura.png
        - name: Dianne Shumay
          title: Scientific Advisor
          image: /img/profile-dianne2.png
board:
    heading: Board of Directors
    description: 
    items:
        - name: Andrew Firlik
          title: Jazz Venture Partners
          image: /img/profile-andrew.png
        - name: John Harris
          title: Jazz Venture Partners
          image: /img/profile-john.png
        - name: Geoff Eich
          title: Blue Note Therapeutics
          image: /img/profile-geoff.png
partners:
    heading: We Can't Do This Alone
    description: Blue Note Therapeutics is honored to work with the National Comprehensive Cancer Network (NCCN) and other leading cancer care organizations in our quest to help cancer patients live better.
    items:
        - image: /img/logo-ncnn.svg
        - image: /img/logo-MSK.png
        - image: /img/logo-Sylvester.png
        - image: /img/logo-CSC.png
pipeline:
  heading: Our Pipeline
  description: Blue Note's products will serve all cancer patients, from early stage through survivorship, in both the in-patient and out-patient settings.
  items:
    - name: BNT001
      stage: Early - Mid Stage
      status: 2
    - name: BNT201
      stage: Acute In-patient
      status: 1
    - name: BNT301
      stage: Late Stage
      status: 0
    - name: BNT401
      stage: Survivorship
      status: 0
---


